Bioelectronics Corp Company Management Evaluation
| BIEL Stock | USD 0.0003 0.0001 50.00% |
Bioelectronics Corp employs about 10 people. The company is managed by 4 executives with a total tenure of roughly 37 years, averaging almost 9.0 years of service per executive, having 2.5 employees per reported executive. Inspection of Bioelectronics Corp's management performance can provide insight into the company performance.
| Andrew Whelan CEO CEO and President Founder, CFO and Director |
Bioelectronics |
Bioelectronics Corp Management Team Effectiveness
The company has return on total asset (ROA) of (0.3367) % which means that it has lost $0.3367 on every $100 spent on assets. This is way below average. Bioelectronics Corp's management efficiency ratios could be used to measure how well Bioelectronics Corp manages its routine affairs as well as how well it operates its assets and liabilities.Bioelectronics Corp Workforce Comparison
Bioelectronics Corp is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 38.0. Bioelectronics Corp totals roughly 10.0 in number of employees claiming about 26% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09. Bioelectronics Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bioelectronics Corp Price Series Summation is a cross summation of Bioelectronics Corp price series and its benchmark/peer.
Bioelectronics Corp Notable Stakeholders
A Bioelectronics Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bioelectronics Corp often face trade-offs trying to please all of them. Bioelectronics Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bioelectronics Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Andrew Whelan | CEO and President Founder, CFO and Director | Profile | |
| Kelly Whelan | President, CEO | Profile | |
| Keith Nalepka | VP Director | Profile | |
| John Martinez | Senior Engineer | Profile |
About Bioelectronics Corp Management Performance
The success or failure of an entity such as Bioelectronics Corp often depends on how effective the management is. Bioelectronics Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bioelectronics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bioelectronics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Bioelectronics Corp Workforce Analysis
Traditionally, organizations such as Bioelectronics Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bioelectronics Corp within its industry.Bioelectronics Corp Manpower Efficiency
Return on Bioelectronics Corp Manpower
| Revenue Per Employee | 160.9K | |
| Revenue Per Executive | 402.4K | |
| Net Loss Per Employee | 29K | |
| Net Loss Per Executive | 72.5K |
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.